# The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans

> **NCT02281396** · PHASE1 · COMPLETED · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 40 (actual)

## Conditions studied

- Rabies
- Healthy

## Interventions

- **BIOLOGICAL:** 2.5IU/ml in rabies vaccine （MRC-5 Cell) humans aged 10-20 years old
- **BIOLOGICAL:** 2.5IU/ml rabies vaccine （MRC-5 Cell) in humans aged 21-60 years old
- **BIOLOGICAL:** 2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 10-20 years old)
- **BIOLOGICAL:** 2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 21-60 years old)

## Key facts

- **NCT ID:** NCT02281396
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281396, "The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02281396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*